Cocrystal Pharma, Inc. (COCP) › Operating IncomeCocrystal Pharma, Inc. (COCP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$32.0K2011: -$3.89M2012: -$2.55M2013: -$4.08M2014: -$5.80M2015: -$53.95M2016: -$105.82M2017: -$8.26M2018: -$62.92M2019: -$48.41M2020: -$9.59M2021: -$14.22M2022: -$38.83M2023: -$18.56M2024: -$17.88M2025: -$9.02M-$9.02M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$9.02M+49.6%2024-$17.88M+3.7%2023-$18.56M+52.2%2022-$38.83M-173.0%2021-$14.22M-48.4%2020-$9.59M+80.2%2019-$48.41M+23.1%2018-$62.92M-661.6%2017-$8.26M+92.2%2016-$105.82M-96.1%2015-$53.95M-830.3%2014-$5.80M-42.1%2013-$4.08M-59.8%2012-$2.55M+34.3%2011-$3.89M-12029.8%2010-$32.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share